What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.71%Above 5Y avg (0.58%)
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
26.8%Sustainable
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.66BCNY
2.33B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
22.38x
Updated Aug 19, 2026
Revenue (TTM)
5.90BCNY
876.02M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
12.44%
Updated Aug 19, 2026
Beta
0.3690x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-43.94%
vs all stocks
Updated Aug 19, 2026
Forward Annual Dividend Yield
0.71%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
15.66BCNY
2.33B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
13.27BCNY
1.97B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
22.38x
Updated Aug 19, 2026
Forward P/E
9.82x
Updated Aug 19, 2026
Price to Sales (TTM)
2.76x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.65×.Updated Aug 19, 2026
Price to Book (MRQ)
2.08x
Updated Aug 19, 2026
Enterprise to Revenue
2.25x
Updated Aug 19, 2026
Enterprise to EBITDA
12.45x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 11.45×.Updated Aug 19, 2026
Gross Margin
49.89%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 54.53%.Updated Aug 19, 2026
Profit Margin
12.44%
Updated Aug 19, 2026
Operating Margin
17.27%
Updated Aug 19, 2026
Return on Assets (TTM)
7.60%
Updated Aug 19, 2026
Return on Equity (TTM)
9.53%
Updated Aug 19, 2026
Revenue (TTM)
5.90BCNY
876.02M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
3.00CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
5.90%
Updated Aug 19, 2026
Gross Profit (TTM)
3.22BCNY
477.65M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
1.16BCNY
172.16M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
733.93MCNY
109.00M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-28.30%
Updated Aug 19, 2026
Operating Cash Flow (TTM)
1.21BCNY
180.25M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
1.06BCNY
157.04M · vs all stocks (USD)
Updated Aug 19, 2026
Forward Annual Dividend Rate
0.0600CNYUpdated Aug 19, 2026
Forward Annual Dividend Yield
0.71%
vs all stocks
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.0600CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
0.71%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.58%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
26.78%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 16.22%.Updated Aug 19, 2026
Minority Interest (Equity)
-8.32MCNYFY2025 · Dec 31, 2025
Revenue
5.82BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.46BCNYFY2025 · Dec 31, 2025
Gross Profit
3.36BCNYFY2025 · Dec 31, 2025
Operating Income
1.17BCNY
173.83M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.01BCNYFY2025 · Dec 31, 2025
Income Tax Expense
225.60MCNYFY2025 · Dec 31, 2025
Net Income
786.17MCNYFY2025 · Dec 31, 2025
EBIT
1.02BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.33BCNYFY2025 · Dec 31, 2025
Research & Development
338.48MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
791.11MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
25.65MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
40.68MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.26MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4087CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4080CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.96BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.96BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
786.17MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
15.34MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
868.45MCNYFY2025 · Dec 31, 2025
Free Cash Flow
788.71MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
2.15BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
786.17MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
56.66MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
9.90MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
15.72MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-79.74MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-32.25MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-6.67BCNYFY2025 · Dec 31, 2025
Sale of Investments
6.27BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-4.68MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-511.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
46.94MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-159.35MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-198.80MCNYFY2025 · Dec 31, 2025
Other Financing Charges
31.32MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-279.89MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.97BSharesUpdated Aug 19, 2026
Float Shares
1.77BSharesUpdated Aug 19, 2026
% Held by Insiders
14.59%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
12.33%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
3.07BCNY
456.04M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
1.56CNYUpdated Aug 19, 2026
Total Debt (MRQ)
65.86MCNY
9.78M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.0084x
Updated Aug 19, 2026
Current Ratio (MRQ)
5.01x
Updated Aug 19, 2026
Book Value per Share (MRQ)
3.97CNYUpdated Aug 19, 2026
Total Assets
8.74BCNY
1.30B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
5.49BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.11BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.25BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
20.74MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.09BCNYFY2025 · Dec 31, 2025
Cash
2.12BCNYFY2025 · Dec 31, 2025
Cash Equivalents
30.99MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.16BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
792.65MCNYFY2025 · Dec 31, 2025
Accounts Receivable
756.95MCNYFY2025 · Dec 31, 2025
Inventory
176.96MCNYFY2025 · Dec 31, 2025
Accounts Payable
420.40MCNYFY2025 · Dec 31, 2025
Short-term Debt
55.67MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
59.69MCNYFY2025 · Dec 31, 2025
Long-term Debt
6.77MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
74.41KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.97BCNYFY2025 · Dec 31, 2025
Retained Earnings
4.64BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
7.64BCNY
1.13B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
6.83CNYUpdated Aug 19, 2026
52-Week High
15.95CNYUpdated Aug 19, 2026
52-Week Change
-43.94%
vs all stocks
Updated Aug 19, 2026
Beta
0.3690x
vs all stocks
Updated Aug 19, 2026
50-Day MA
7.94CNYUpdated Aug 19, 2026
200-Day MA
10.10CNYUpdated Aug 19, 2026
Avg 10-Day Volume
52.85MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
67.74MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
0.3700CNYUpdated Aug 19, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.89: safe zoneNotable
Altman Z-Score: 10.89
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $2.33B, above the global median of $1.18BNotable
Market cap (USD): 2,325,630,714.07Global Median: 1,179,398,897.704
Revenue is $876.02M, above the global median of $534.05MNotable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityLow-Leverage Liquidity Configuration